BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

Early Intervention in Psychiatry, published by WILEY, is an esteemed academic journal dedicated to advancing the field of psychiatry and mental health through rigorous research and innovative practices. Established in 2007 and continuing through 2024, this journal serves as a critical resource for researchers, clinicians, and students interested in the early detection and treatment of psychiatric disorders. With an ISSN of 1751-7885 and an E-ISSN of 1751-7893, it is recognized for its significant contributions, placing in the Q3 quartile in Biological Psychiatry and Q2 in Psychiatry and Mental Health as of 2023. The journal boasts impressive Scopus rankings, being placed 12th in Nursing - Psychiatric Mental Health and 27th in Neuroscience - Biological Psychiatry, showcasing its impact within the scientific community. While not an open-access journal, its findings are pivotal for those seeking to enhance mental health interventions. Early Intervention in Psychiatry is committed to fostering knowledge and improving practices that ultimately contribute to better mental health outcomes globally.

Journal of Intellectual Disabilities and Offending Behaviour, published by EMERALD GROUP PUBLISHING LTD, serves as a pivotal platform for the exploration of interdisciplinary perspectives surrounding the complex interplay between intellectual disabilities and offending behavior. With an ISSN of 2050-8824 and an E-ISSN of 2050-8832, this journal aims to foster insightful discourse and advance knowledge in critical areas including clinical psychology, psychiatric and mental health studies, and forensic medicine. Ranked in the lower quartiles for 2023 across major categories—most notably Q3 in Pathology and Forensic Medicine—this journal seeks to address urgent research gaps and encourage innovative practices that support affected individuals. Although currently operating under a traditional access model, the importance of its contributions to academia cannot be overstated, particularly as it relates to enhancing our understanding of behaviors stemming from intellectual disabilities. Researchers, professionals, and students alike will find valuable resources and a collaborative environment in which to investigate these vital issues, thereby shaping future investigations and interventions.

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

The International Journal of Mental Health Promotion, published by TECH SCIENCE PRESS, serves as a vital platform for advancing research in the realms of mental health and public health policy. With a focus that spans across key categories such as Psychiatry and Mental Health, as well as Public Health and Environmental Health, this journal is recognized in the Q3 quartile for 2023, positioning itself to foster impactful dialogue among scholars, practitioners, and policymakers. Although the journal does not currently provide open access, it retains a significant role in disseminating essential findings that inform mental health promotion strategies globally. Researchers and students alike will find the journal's work invaluable in addressing contemporary challenges in mental health systems, contributing to evidence-based practice and policy formulation. With an emphasis on interdisciplinary collaboration and innovation, the International Journal of Mental Health Promotion is committed to enhancing the understanding of mental health trends and interventions from 2015 to 2024, ultimately enriching the scholarly landscape and improving mental health outcomes worldwide.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

The Journal of Applied Research in Intellectual Disabilities, published by Wiley, is a pioneering platform dedicated to advancing knowledge and promoting best practices in the field of intellectual disabilities. With an impressive impact factor reflecting its significance—ranking in the Q2 category for Developmental and Educational Psychology and the Q1 category for Education in 2023—this journal serves as an essential resource for researchers, practitioners, and students alike. Its wide contribution to social sciences is evidenced by its high standings in Scopus rankings, positioned at Rank #297 in Education and Rank #103 in Developmental and Educational Psychology. This journal not only fosters innovative empirical and theoretical research but also encourages the dissemination of practical solutions to enhance the quality of life for individuals with intellectual disabilities. With access options available to meet diverse needs, including open access, it strives to make impactful research widely available, bridging the gap between academic research and practical application.

PSICOTHEMA is a premier open-access journal dedicated to the field of psychology, published by the COLEGIO OFICIAL DE PSICOLOGOS DE ASTURIAS in Spain. With an impressive impact factor and a distinguished presence in the academic community, PSICOTHEMA has established itself as a vital platform for disseminating innovative research and insights in psychology since its inception in 1989. The journal embraces a broad scope, covering diverse topics within psychology and ranks within the top quartile (Q1) in the 'Miscellaneous Psychology' category as of 2023, making it a key resource for researchers and practitioners alike. With a current Scopus rank of #32 out of 216 in General Psychology and an 85th percentile ranking, it underscores PSICOTHEMA’s commitment to quality and relevance. Researchers, professionals, and students are encouraged to explore its extensive repository of articles, which promotes both theoretical knowledge and practical applications in the ever-evolving landscape of psychological science.

Community Mental Health Journal is a leading publication in the field of mental health, managed by Springer and based in the United States. Since its inception in 1965, this journal has provided a critical platform for advancements in mental health research and community practices, with a convergence set to continue until 2024. It boasts an impressive impact factor and ranks in the first quartile (Q1) for Health (Social Science) as well as Public Health, Environmental and Occupational Health, underscoring its significance in interdisciplinary scholarship. The journal caters to a diverse audience, including researchers, practitioners, and students, fostering a deeper understanding of community mental health issues. With a commitment to highlighting innovative research and practical applications, the Community Mental Health Journal serves as an invaluable resource for those dedicated to improving mental health outcomes in communities globally.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.